10-K Decoder · All companies

Alnylam Pharmaceuticals, Inc.

ALNY · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$3.71B$2.25B+65.2%
Operating income$502M−$177M
Net income$314M−$278M

Questions

What was Alnylam's revenue in FY2025?
$3.71B in FY2025 (Fiscal year ended Dec 31, 2025), +65.2% vs $2.25B a year earlier, per its 10-K filed Feb 2026.
Was Alnylam profitable in FY2025?
Yes: net income was $314M and operating income $502M in FY2025.